anmelden
GSK Aktie
22,08
EUR
-0,42
EUR
-1,87
%
18,96
GBP
-0,32
GBP
-1,63
%
GSK jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Marktkap. 90,39 Mrd. EUR
KGV 12,93 Div. Rendite 3,62%WKN A3DMB5
ISIN GB00BN7SWP63
Symbol GLAXF
AI Analyse
Werbung
GSK Aktie Analyse
| 02.11.22 | GSK Neutral | UBS AG | |
| 27.10.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 27.10.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 25.10.22 | GSK Hold | Deutsche Bank AG | |
| 24.10.22 | GSK Equal Weight | Barclays Capital | |
| 24.10.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 21.10.22 | GSK Neutral | UBS AG | |
| 14.10.22 | GSK Hold | Deutsche Bank AG | |
|
Werbung
|
|||
| 14.10.22 | GSK Equal Weight | Barclays Capital | |
| 13.10.22 | GSK Neutral | UBS AG | |
| 12.10.22 | GSK Neutral | Credit Suisse Group | |
| 07.10.22 | GSK Hold | Deutsche Bank AG | |
| 04.10.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 03.10.22 | GSK Hold | Deutsche Bank AG | |
| 27.09.22 | GSK Equal Weight | Barclays Capital | |
| 26.09.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 21.09.22 | GSK Hold | Deutsche Bank AG | |
| 15.09.22 | GSK Neutral | Credit Suisse Group | |
| 15.09.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 14.09.22 | GSK Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.09.22 | GSK Hold | Jefferies & Company Inc. | |
| 07.09.22 | GSK Hold | Deutsche Bank AG | |
| 30.08.22 | GSK Equal Weight | Barclays Capital | |
| 25.08.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 25.07.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 21.07.22 | GSK Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 20.07.22 | GSK Underperform | Credit Suisse Group | |
| 20.07.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 20.07.22 | GSK Neutral | UBS AG | |
| 18.07.22 | GSK Hold | Deutsche Bank AG | |
| 18.07.22 | GSK Equal Weight | Barclays Capital | |
| 15.07.22 | GSK Underperform | Credit Suisse Group | |
| 11.07.22 | GSK Neutral | UBS AG | |
| 05.07.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 01.07.22 | GSK Underperform | Credit Suisse Group | |
| 29.06.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 23.06.22 | GSK Buy | Jefferies & Company Inc. | |
| 13.06.22 | GSK Hold | Deutsche Bank AG | |
| 10.06.22 | GSK Neutral | UBS AG | |
| 10.06.22 | GSK Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 10.06.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 06.06.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 01.06.22 | GSK Hold | Deutsche Bank AG | |
| 01.06.22 | GSK Equal Weight | Barclays Capital | |
| 31.05.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 31.05.22 | GSK Neutral | UBS AG | |
| 27.05.22 | GSK Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 26.05.22 | GSK Buy | Jefferies & Company Inc. | |
| 19.05.22 | GSK Hold | Deutsche Bank AG | |
| 13.05.22 | GSK Neutral | JP Morgan Chase & Co. | |
Werbung
Werbung
